For the details of New Leaf Venture Partners, L.L.C.'s stock buys and sells, go to https://www.gurufocus.com/guru/new+leaf+venture+partners%2C+l.l.c./current-portfolio/portfolio
These are the top 5 holdings of New Leaf Venture Partners, L.L.C.- Deciphera Pharmaceuticals Inc (DCPH) - 4,104,140 shares, 30.16% of the total portfolio.
- Principia Biopharma Inc (PRNB) - 2,625,713 shares, 28.27% of the total portfolio.
- Arvinas Inc (ARVN) - 2,283,048 shares, 10.67% of the total portfolio.
- Neuronetics Inc (STIM) - 1,543,115 shares, 7.45% of the total portfolio.
- Aptinyx Inc (APTX) - 3,533,424 shares, 4.53% of the total portfolio. Shares added by 7.40%
New Leaf Venture Partners, L.L.C. initiated holding in Chiasma Inc. The purchase prices were between $2.98 and $6.93, with an estimated average price of $4.37. The stock is now traded at around $6.07. The impact to a portfolio due to this purchase was 0.66%. The holding were 400,000 shares as of .
Sold Out: WAVE Life Sciences Ltd (WVE)New Leaf Venture Partners, L.L.C. sold out a holding in WAVE Life Sciences Ltd. The sale prices were between $32.69 and $47.91, with an estimated average price of $40.58.
Sold Out: CRISPR Therapeutics AG (CRSP)New Leaf Venture Partners, L.L.C. sold out a holding in CRISPR Therapeutics AG. The sale prices were between $28.02 and $40.87, with an estimated average price of $34.47.
Sold Out: Proteon Therapeutics Inc (PRTO)New Leaf Venture Partners, L.L.C. sold out a holding in Proteon Therapeutics Inc. The sale prices were between $0.5 and $3.75, with an estimated average price of $2.84.
Here is the complete portfolio of New Leaf Venture Partners, L.L.C.. Also check out:
1. New Leaf Venture Partners, L.L.C.'s Undervalued Stocks
2. New Leaf Venture Partners, L.L.C.'s Top Growth Companies, and
3. New Leaf Venture Partners, L.L.C.'s High Yield stocks
4. Stocks that New Leaf Venture Partners, L.L.C. keeps buying
